Skip to main content
SpringerLink
Log in

Environmental factors, serum biomarkers and risk of atrial fibrillation: an exposure-wide umbrella review of meta-analyses

  • UMBRELLA REVIEW
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia. We designed an umbrella review to systematically assess the epidemiological credibility of the associations of non-genetic factors with risk of AF. We searched PubMed and EMBASE from inception to December 31, 2018 to identify systematic reviews and meta-analyses of observational studies for the association of non-genetic factors with risk of AF. For each meta-analysis, we used the random-effects model, and we estimated the 95% confidence and prediction intervals. We also assessed between-study heterogeneity, small-study effects and excess significance bias. We identified 34 eligible papers that examined 51 associations of 42 unique non-genetic factors with risk of AF. Eighteen associations remained statistically significant at P value < 1 × 10−6. Thirty-one associations presented large or very large between-study heterogeneity. Eight associations presented evidence for small-study effects and 13 associations had evidence for excess significance bias. Ten associations, i.e. corrected QT interval, alcohol consumption (highest vs. lowest category, per 1 drink/day increase), body mass index (> 30 units vs. < 30 units, per 5 units increase), waist circumference, body weight, type 2 diabetes mellitus, and smoking (ever vs. never, per 10 cigarettes/day increase) were supported by convincing or highly suggestive evidence in meta-analyses of prospective cohort studies. Type 2 diabetes mellitus, markers of adiposity, alcohol consumption, smoking, and corrected QT interval constitute credible risk factors of AF. Our proposed grading may guide the design of future studies, including Mendelian randomization studies, to assess whether these associations are causal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

The datasets analysed and generated during the current study are available from the corresponding author on reasonable request.

References

  1. Rienstra M, McManus DD, Benjamin EJ. Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making? Circulation. 2012;125:e941–6.

    PubMed  PubMed Central  Google Scholar 

  2. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation. Circulation. 2014;129:837–47.

    PubMed  Google Scholar 

  3. Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Glob Heart. 2014;9:113–9.

    PubMed  Google Scholar 

  4. Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet. 2012;379:648–61.

    PubMed  Google Scholar 

  5. Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354:i4482.

    PubMed  Google Scholar 

  6. Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136:583–96.

    PubMed  Google Scholar 

  7. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–962.

    PubMed  Google Scholar 

  8. Benjamin EJ, Chen P-S, Bild DE, Mascette AM, Albert CM, Alonso A, et al. Prevention of atrial fibrillation. Circulation. 2009;119:606–18.

    PubMed  PubMed Central  Google Scholar 

  9. Ioannidis JPA. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009;181:488–93.

    PubMed  PubMed Central  Google Scholar 

  10. Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JPA. Environmental risk factors and Parkinson’s disease: an umbrella review of meta-analyses. Parkinsonism Relat Disord. 2016;23:1–9.

    PubMed  Google Scholar 

  11. Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2017;13:406–18.

    PubMed  Google Scholar 

  12. Belbasis L, Stefanaki I, Stratigos AJ, Evangelou E. Non-genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: an umbrella review of meta-analyses. J Dermatol Sci. 2016;84:330–9.

    PubMed  Google Scholar 

  13. Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS ONE. 2018;13:e0194127.

    PubMed  PubMed Central  Google Scholar 

  14. Belbasis L, Dosis V, Evangelou E. Elucidating the environmental risk factors for rheumatic diseases: an umbrella review of meta-analyses. Int J Rheum Dis. 2018;21:1514–24.

    PubMed  Google Scholar 

  15. Bellou V, Belbasis L, Konstantinidis AK, Evangelou E. Elucidating the risk factors for chronic obstructive pulmonary disease: an umbrella review of meta-analyses. Int J Tuberc Lung Dis. 2019;23:58–66.

    CAS  PubMed  Google Scholar 

  16. Belbasis L, Savvidou MD, Kanu C, Evangelou E, Tzoulaki I. Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Med. 2016;14:147.

    PubMed  PubMed Central  Google Scholar 

  17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    CAS  PubMed  Google Scholar 

  18. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–6.

    CAS  PubMed  Google Scholar 

  19. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    PubMed  Google Scholar 

  20. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    PubMed  PubMed Central  Google Scholar 

  21. Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137–59.

    PubMed  PubMed Central  Google Scholar 

  22. Higgins JPT. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158–60.

    PubMed  Google Scholar 

  23. Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.

    PubMed  Google Scholar 

  24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Ioannidis JPA, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4:245–53.

    PubMed  Google Scholar 

  26. Ioannidis JPA. Clarifications on the application and interpretation of the test for excess significance and its extensions. J Math Psychol. 2013;57:184–7.

    Google Scholar 

  27. Lubin JH, Gail MH. On power and sample size for studying features of the relative odds of disease. Am J Epidemiol. 1990;131:552–66.

    CAS  PubMed  Google Scholar 

  28. Baumgartner C, da Costa BR, Collet T-H, Feller M, Floriani C, Bauer DC, et al. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation. 2017;136:2100–16.

    PubMed  PubMed Central  Google Scholar 

  29. Kivimäki M, Nyberg ST, Batty GD, Kawachi I, Jokela M, Alfredsson L, et al. Long working hours as a risk factor for atrial fibrillation: a multi-cohort study. Eur Heart J. 2017;38:2621–8.

    PubMed  PubMed Central  Google Scholar 

  30. Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64:281–9.

    CAS  PubMed  Google Scholar 

  31. Sidhu K, Tang A. Modifiable risk factors in atrial fibrillation: the role of alcohol, obesity, and sleep apnea. Can J Cardiol. 2017;33:947–9.

    PubMed  Google Scholar 

  32. Voskoboinik A, Prabhu S, Ling L, Kalman JM, Kistler PM. Alcohol and atrial fibrillation. J Am Coll Cardiol. 2016;68:2567–76.

    CAS  PubMed  Google Scholar 

  33. Fabritz L, Guasch E, Antoniades C, Bardinet I, Benninger G, Betts TR, et al. Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol. 2016;13:230–7.

    CAS  PubMed  Google Scholar 

  34. Chatterjee NA, Giulianini F, Geelhoed B, Lunetta KL, Misialek JR, Niemeijer MN, et al. Genetic obesity and the risk of atrial fibrillation: causal estimates from Mendelian randomization. Circulation. 2017;135:741–54.

    PubMed  Google Scholar 

  35. Tikkanen E, Gustafsson S, Knowles JW, Perez M, Burgess S, Ingelsson E. Body composition and atrial fibrillation: a Mendelian randomization study. Eur Heart J. 2019;40:1277–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014;12:31–42.

    CAS  PubMed  Google Scholar 

  37. Wong CX, Sun MT, Odutayo A, Emdin CA, Mahajan R, Lau DH, et al. Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9:e004378.

    PubMed  Google Scholar 

  38. Lau DH, Schotten U, Mahajan R, Antic NA, Hatem SN, Pathak RK, et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. Eur Heart J. 2016;37:1573–81.

    CAS  PubMed  Google Scholar 

  39. Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Diabetes Complicat. 2018;32:501–11.

    Google Scholar 

  40. Harati H, Zanetti D, Rao A, Gustafsson S, Perez M, Ingelsson E, et al. No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation. Diabetologia. 2019;62:800–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, et al. Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration. Circulation. 2017;135:1851–67.

    PubMed  Google Scholar 

  42. US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening for atrial fibrillation with electrocardiography: US preventive services task force recommendation statement. JAMA. 2018;320:478–84.

    Google Scholar 

  43. Ioannidis JPA, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120–32.

    PubMed  Google Scholar 

  44. Benjamin DJ, Berger JO, Johannesson M, Nosek BA, Wagenmakers E-J, Berk R, et al. Redefine statistical significance. Nat Hum Behav. 2018;2:6–10.

    PubMed  Google Scholar 

  45. Johnson VE. Revised standards for statistical evidence. Proc Natl Acad Sci U S A. 2013;110:19313–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.

    PubMed  Google Scholar 

  47. Alonso A, Misialek JR, Michos ED, Eckfeldt J, Selvin E, Soliman EZ, et al. Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Europace. 2016;18:1143–9.

    PubMed  PubMed Central  Google Scholar 

  48. Asad Z, Abbas M, Javed I, Korantzopoulos P, Stavrakis S. Obesity is associated with incident atrial fibrillation independent of gender: a meta-analysis. J Cardiovasc Electrophysiol. 2018;29:725–32.

    PubMed  Google Scholar 

  49. Aune D, Sen A, Ó’Hartaigh B, Janszky I, Romundstad PR, Tonstad S, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2017;27:504–17.

    CAS  PubMed  Google Scholar 

  50. Aune D, Sen A, Schlesinger S, Norat T, Janszky I, Romundstad P, et al. Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32:181–92.

    PubMed  PubMed Central  Google Scholar 

  51. Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol. 2018;25:1437–51.

    PubMed  Google Scholar 

  52. Bang CN, Greve AM, Abdulla J, Køber L, Gislason GH, Wachtell K. The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis. Int J Cardiol. 2013;167:624–30.

    PubMed  Google Scholar 

  53. Cardoso R, Garcia D, Fernandes G, He LI, Lichtenberger P, Viles-Gonzalez J, et al. The prevalence of atrial fibrillation and conduction abnormalities in Chagas’ disease: a meta-analysis. J Cardiovasc Electrophysiol. 2016;27:161–9.

    PubMed  Google Scholar 

  54. Chokesuwattanaskul R, Thongprayoon C, Sharma K, Congrete S, Tanawuttiwat T, Cheungpasitporn W. Associations of sleep quality with incident atrial fibrillation: a meta-analysis. Intern Med J. 2018;48:964–72.

    PubMed  Google Scholar 

  55. Emdin CA, Odutayo A, Wong CX, Tran J, Hsiao AJ, Hunn BHM. Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am J Cardiol. 2016;118:511–9.

    PubMed  Google Scholar 

  56. Fransson EI, Nordin M, Magnusson Hanson LL, Westerlund H. Job strain and atrial fibrillation—results from the Swedish Longitudinal Occupational Survey of Health and meta-analysis of three studies. Eur J Prev Cardiol. 2018;25:1142–9.

    PubMed  Google Scholar 

  57. Himmelreich JCL, Lucassen WAM, Heugen M, Bossuyt PMM, Tan HL, Harskamp RE, et al. Frequent premature atrial contractions are associated with atrial fibrillation, brain ischaemia, and mortality: a systematic review and meta-analysis. EP Eur. 2019;21:698–707.

    Google Scholar 

  58. Kim SY, Kim MJ, Cadarette SM, Solomon DH. Bisphosphonates and risk of atrial fibrillation: a meta-analysis. Arthritis Res Ther. 2010;12:R30.

    PubMed  PubMed Central  Google Scholar 

  59. Kwok CS, Anderson SG, Myint PK, Mamas MA, Loke YK. Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2014;177:467–76.

    PubMed  Google Scholar 

  60. Kwok CS, Rashid M, Beynon R, Barker D, Patwala A, Morley-Davies A, et al. Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis. Heart. 2016;102:672–80.

    CAS  PubMed  Google Scholar 

  61. Larsson SC, Drca N, Jensen-Urstad M, Wolk A. Coffee consumption is not associated with increased risk of atrial fibrillation: results from two prospective cohorts and a meta-analysis. BMC Med. 2015;13:207.

    PubMed  PubMed Central  Google Scholar 

  62. Larsson SC, Drca N, Jensen-Urstad M, Wolk A. Chocolate consumption and risk of atrial fibrillation: two cohort studies and a meta-analysis. Am Heart J. 2018;195:86–90.

    PubMed  Google Scholar 

  63. Li F-R, Chen G-C, Qin J, Wu X. Dietary fish and long-chain n-3 polyunsaturated fatty acids intake and risk of atrial fibrillation: a meta-analysis. Nutrients. 2017;9:955.

    PubMed Central  Google Scholar 

  64. Liu G, Yan Y-P, Zheng X-X, Xu Y-L, Lu J, Hui R-T, et al. Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation. Am J Cardiol. 2014;114:1523–9.

    CAS  PubMed  Google Scholar 

  65. Meng L, Yang Y, Zhang Z, Li G, Liu T. Predictive value of circulating fibroblast growth factor-23 on atrial fibrillation: a meta-analysis. Int J Cardiol. 2016;210:68–71.

    PubMed  Google Scholar 

  66. Qi W, Zhang N, Korantzopoulos P, Letsas KP, Cheng M, Di F, et al. Serum glycated hemoglobin level as a predictor of atrial fibrillation: a systematic review with meta-analysis and meta-regression. PLoS ONE. 2017;12:e0170955.

    PubMed  PubMed Central  Google Scholar 

  67. Ricci C, Gervasi F, Gaeta M, Smuts CM, Schutte AE. Physical activity volume in relation to risk of atrial fibrillation. A non-linear meta-regression analysis. Eur J Prev Cardiol. 2018;25:857–66.

    PubMed  Google Scholar 

  68. Shang W, Li L, Huang S, Zeng R, Huang L, Ge S, et al. Chronic kidney disease and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies. PLoS ONE. 2016;11:e0155581.

    PubMed  PubMed Central  Google Scholar 

  69. Tse G, Wong CW, Gong M, Wong WT, Bazoukis G, Wong SH, et al. Predictive value of inter-atrial block for new onset or recurrent atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2018;250:152–6.

    PubMed  Google Scholar 

  70. Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis. Int J Rheum Dis. 2017;20:434–41.

    CAS  PubMed  Google Scholar 

  71. Ungprasert P, Srivali N, Kittanamongkolchai W. Psoriasis and risk of incident atrial fibrillation: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol. 2016;82:489–97.

    PubMed  Google Scholar 

  72. Wijarnpreecha K, Boonpheng B, Thongprayoon C, Jaruvongvanich V, Ungprasert P. The association between non-alcoholic fatty liver disease and atrial fibrillation: a meta-analysis. Clin Res Hepatol Gastroenterol. 2017;41:525–32.

    PubMed  Google Scholar 

  73. Yan J, She Q, Zhang Y, Cui C, Zhang G. The association between arrhythmia and helicobacter pylori infection: a meta-analysis of case-control studies. Int J Environ Res Public Health. 2016;13:1139.

    PubMed Central  Google Scholar 

  74. Youssef I, Kamran H, Yacoub M, Patel N, Goulbourne C, Kumar S, et al. Obstructive sleep apnea as a risk factor for atrial fibrillation: a meta-analysis. J Sleep Disord Ther 2018;7(1):282.

    PubMed  PubMed Central  Google Scholar 

  75. Zhang C-H, Huang D-S, Shen D, Zhang L-W, Ma Y-J, Wang Y-M, et al. Association between serum uric acid levels and atrial fibrillation risk. Cell Physiol Biochem. 2016;38:1589–95.

    CAS  PubMed  Google Scholar 

  76. Zhang N, Gong M, Tse G, Zhang Z, Meng L, Yan BP, et al. Prolonged corrected QT interval in predicting atrial fibrillation: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2018;41:321–7.

    PubMed  Google Scholar 

Download references

Funding

Lazaros Belbasis is supported by a Ph.D. scholarship funded by Greek State Scholarships Foundation.

Author information

Authors and Affiliations

  1. Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece

    Lazaros Belbasis, Michail C. Mavrogiannis, Maria Emfietzoglou & Evangelos Evangelou

  2. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK

    Evangelos Evangelou

Authors
  1. Lazaros Belbasis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michail C. Mavrogiannis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Emfietzoglou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Evangelos Evangelou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Evangelos Evangelou.

Ethics declarations

Conflict of interest

The authors have declared that no competing interests exist.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 31 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Belbasis, L., Mavrogiannis, M.C., Emfietzoglou, M. et al. Environmental factors, serum biomarkers and risk of atrial fibrillation: an exposure-wide umbrella review of meta-analyses. Eur J Epidemiol 35, 223–239 (2020). https://doi.org/10.1007/s10654-020-00618-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-020-00618-3

Keywords

Search

Navigation